Syngo NATIVE Contrast Enhanced 3D MRA on 3T Verio Magnet

Completed

• Conditions: Vascular Disease

• Registration Number: NCT02065648
• Lead Sponsor: Cedars-Sinai Medical Center

Brief Summary

The purpose of the study is to compare non-contrast abdominal MR Angiogram (MRA) syngo NATIVE sequence performed on a 3T Verio Siemens magnet to a standard contrast-enhanced MRA performed as part of routine clinical care in patients with normal renal function to determine if the non-contrast NATIVE sequence is a viable alternative to contrast enhanced MRA in patients with renal insufficiency. There are no interventions--this is an observational study.

Detailed Description

If the NATIVE sequence proves to be a viable alternative to contrast enhanced MRA it will provide imaging physicians with the diagnostic tool to assess vascular disease in patients with renal insufficiency without placing them at risk for additional co-morbidities.

Study Timeline

• Study Start: 2012-05
• Study First Submitted: 2014-01-17
• Study First Submitted QC: 2014-02-14
• Study First Posted: 2014-02-19
• Primary Completion: 2015-03
• Study Completion: 2015-03
• Status Verified: 2025-02
• Last Update Submitted: 2025-02-10
• Last Update Posted: 2025-02-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Over age 18 Signed informed consent Referred for standard of care MRA

Exclusion Criteria

No contra-indications for MRI/MRA ie implants which could interfere with magnets Renal insufficiency which would preclude use of contrast-enhanced contrast for a standard of care MRA

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Effectiveness of non-contrast enhanced MRA sequence	36 months	Compare non-contrast enhanced MRA images with contrast-enhanced MRA images.

Trial Locations

Locations (1)

Cedars-Sinai Medical Center; 🇺🇸 Los Angeles, California, United States